期刊
CELL REPORTS
卷 24, 期 7, 页码 1830-1841出版社
CELL PRESS
DOI: 10.1016/j.celrep.2018.07.036
关键词
-
类别
资金
- JSPS KAKENHI [15K19082, 17K15674, 15K09036, 17K08802, 17KT0132]
- National Center for Global Health and Medicine [25-107, 26-110, 29-1008]
- Grants-in-Aid for Scientific Research [17K15674, 17KT0132, 15K19082, 15K09036, 17K08802] Funding Source: KAKEN
Lnk/Sh2b3 is an adaptor protein that negatively regulates cytokine signaling in lymphohematopoiesis. A missense variant within the LNK/SH2B3 gene has been reported to be a risk variant for several autoimmune diseases, including diabetes. We found that glucose tolerance and insulin responses were impaired in Lnk(-/)(-) mice. Moreover, immune cells such as group 1 innate lymphoid cells (G1-ILCs), CD8(+) T cells, and M1 macrophages accumulated in adipose tissue. When Lnk(-/)(-) mice were crossed with Il15(-/- )mice or depleted of G1-ILCs but not CD8(+) T cells, glucose intolerance and adipose inflammation were ameliorated. Lnk(-/)(-) G1-ILCs showed activated phenotypes as well as enhanced reactivity for IL-15, and administration of a JAK inhibitor improved glucose tolerance. Accordingly, a high-fat diet greatly worsened glucose intolerance in Lnk(-/)(-) mice. Thus, Lnk/Sh2b3 controls homeostasis in adipose tissue and reduces the risk of onset of diabetes by regulating the expansion and activation of IL-15-dependent adipose G1-ILCs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据